We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Followup Of Patients With Interstitial Cystitis Responsive To Treatment With Intravesical Bacillus Calmette Guerin Or Placebo
Clinical Trials / Drug Trials UroToday.com - The Interstitial Cystitis Clinical Trials Group (ICCTG) recently reported the results of a randomized, double-blind, placebo controlled clinical trial of intravesical bacillus Calmette-Guerin (BCG). After 34 weeks of follow-up, there was no statistically significant difference between BCG and placebo in the rate of responders based on a global response assessment.
Custom Search
